Ivermectin is a trusted antiparasitic medication widely used to treat conditions such as onchocerciasis and strongyloidiasis by disrupting chloride ion channels, leading to parasite paralysis and elimination. With a well-documented safety profile, it remains a key treatment option for parasitic infections. Additionally, ongoing research continues to explore its broader therapeutic potential.

This is a compounded preparation. Compounded preparations are not reviewed or approved by the U.S. Food and Drug Administration (FDA) for safety, efficacy, or quality.